Japan donates $7.9 million to support Refugees and Host Communities in Uganda

The Japanese Government has donated 7.9 million US Dollars (29.5 billion Shillings) to support refugees and improve food security in the Karamoja sub-region. The donation has been channeled through five United Nations organizations which include United Nations High Commission for Refugees(UNHCR), World Food Program (WFP), United Nations Children’s Fund (UNICEF), United Nations Women (UN Women),…

Uganda Launches Satellite Laboratory at Fort Portal Hospital

The Ministry of Health has launched a Satellite Laboratory at Fort Portal Regional Referral Hospital. The facility, constructed under the Uganda COVID-19 Response and Preparedness Project is expected to improve clinical research at the hospital upon its completion. The construction will cost four billion Shillings while another 1.3 Billion Shillings will be spent on equipping…

Obstetricians, Gynecologists Ask For Immediate Deployment, Payment Of Interns

Obstetricians and Gynecologists have joined the push to demand for immediate deployment and payment of medical interns warning government not to demand accountability for women dying in labor when they further delay.   Dr. Othiniel Musana, the President of the Association of Obstetricians and Gynecologists of Uganda (AOGU) told URN in an interview that medical…

CSOs Want Gilead Pharma to Allow Companies Make Generics Out of Their Products

Civil Society Organizations (CSOs) have expressed concern over restrictions by global HIV and Hepatitis drugs manufacturer barring other pharmaceutical companies from replicating their medicines to make generics. Speaking to journalists during a press conference on Wednesday, Kenneth Mwehonge, the Executive Director HEPs Uganda said drugs made by Gilead, an American Biopharmaceutical company are too expensive…

Oxford biotech firm secures £13.2m to develop world’s first treatment for rare, incurable and deadly disease

A UK biotech company has announced £13m of investment that they believe will fund them through to clinical trials next year of the world’s first treatment for a rare, incurable and deadly disease. The investment has been raised by Oxfordshire-based SynaptixBio, whose aim is to tackle TUBB4a leukodystrophy – a genetic and debilitating condition that mainly…